Award recordCONTRACT

ACCREDO HEALTH GROUP, INC

PIID 36C26025P0979· VHA· 260-NETWORK CONTRACT OFFICE 20 (36C260)· 6505 · DRUGS AND BIOLOGICALS· FY2025· $13,364 net obligations· UEI LERPSGUE3528· TN

Description

LUMRYX 7.5G

First action · last action
2025-07-01 · 2026-04-03
Transactions
2
First transaction's obligation
$40,092
Base + all options value (sum of deltas)
$13,364
Extent competed
NOT COMPETED
Other than full & open authority
ONLY ONE SOURCE-OTHER (FAR 6.302-1 OTHER)
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 2 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$40,092$0Base award · 2025-07-01 · this action $40,092 · running total $40,092Modification P00001 · 2026-04-03 · this action -$26,728 · running total $13,364
  • Base2025-07-01+$40,092= $40,092
  • Mod P000012026-04-03-$26,728= $13,364
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2025-07-01+$40,092$40,092LUMRYX 7.5G
Mod P00001· FUNDING ONLY ACTION2026-04-03−$26,728$13,364LUMRYX 7.5G

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI LERPSGUE3528)

AwardOffice · PSC / listingNet obligationsFY
36C25226P0445252-NETWORK CONTRACT OFFICE 12 (36C252) · 6505 · DRUGS AND BIOLOGICALS$349,099FY2026
36C25926P0120NETWORK CONTRACT OFFICE 19 (36C259) · 6505 · DRUGS AND BIOLOGICALS$11,198FY2026
36C25925P1097NETWORK CONTRACT OFFICE 19 (36C259) · 6505 · DRUGS AND BIOLOGICALS$11,198FY2025
36C24225P1342242-NETWORK CONTRACT OFFICE 02 (36C242) · 6505 · DRUGS AND BIOLOGICALS$17,490FY2025
36C24225P1200242-NETWORK CONTRACT OFFICE 02 (36C242) · 6505 · DRUGS AND BIOLOGICALS$10,122FY2025
36C24225P1097242-NETWORK CONTRACT OFFICE 02 (36C242) · 6505 · DRUGS AND BIOLOGICALS$10,122FY2025

Other recipients under 6505 from 260-NETWORK CONTRACT OFFICE 20 (36C260) (most recent first)

AwardRecipientOfficeNet obligationsFY
36C26026F0379COSETTE PHARMACEUTICALS, INC.260-NETWORK CONTRACT OFFICE 20 (36C260)$3,466FY2026
36C26026P0671MCKESSON PLASMA AND BIOLOGICS LLC260-NETWORK CONTRACT OFFICE 20 (36C260)$18,262FY2026
36C26026F0349AGIOS PHARMACEUTICALS, INC.260-NETWORK CONTRACT OFFICE 20 (36C260)$73,080FY2026
36C26026F0306BRACCO DIAGNOSTICS INC.260-NETWORK CONTRACT OFFICE 20 (36C260)$337,422FY2026
36C26026F0298PROGENICS PHARMACEUTICALS INC260-NETWORK CONTRACT OFFICE 20 (36C260)$469,134FY2026

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C26025P0979_3600_-NONE-_-NONE- · retrieved 2026-09-26.